Search Results

240 results for alxn

13 Biotechnology Stocks to Sell Now

By Portfolio Grader

This week, the overall grades of 13 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

10 Biotechnology Stocks to Sell Now

By Portfolio Grader

This week, the overall grades of 10 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

7 Stocks Goldman Sachs Thinks Are Set to Rip Higher

By Harriet Lefton, Writer, TipRanks

Yes the market is tricky right now. But Goldman Sachs has a report on stocks with the potential to explode. Here I single out the…

10 Must-Own Stocks With Great Earnings, Sales and Guidance

By Jeff Reeves

The best stocks to buy after earnings are those that have beaten the mark on sales, profits and guidance. Here are 10 picks to consider…

3 Blue Chip Stocks to Fight the Market Blues

By Louis Navellier, Editor, Growth Investor

Three strong blue chip companies can form the basis of a solid portfolio, and these three are running in high gear and should be added…

Top 5 Blue-Chip Stocks for February

By Louis Navellier, Editor, Growth Investor

You’d be lucky to own shares of any one of these champions. They have the immediate growth potential any investor would want. See this month’s…

3 Big Stock Charts for Thursday: Express Scripts Holding Co, Alexion Pharmaceuticals and Ventas

By James Brumley, InvestorPlace Feature Writer

Stock charts of Express Scripts, Ventas and Alexion Pharmaceuticals are shaping up as your best bets as the week nears its end.

7 ‘Baby’ Booming Health Care Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor

Health care spending is expected to skyrocket thanks to the aging baby boomers. It’s no wonder stocks like ABC are doing so well. Buy them…

Synageva 2.0 – Which Biotech Stock Will Be Bought Next?

By Jeff Reeves

Synageva doubled overnight on a biotech buyout deal. So which stock in the sector will be next? Maybe Isis or BioMarin? Someone else?

5 Top Stock Picks to Start the Summer

By Louis Navellier, Editor, Growth Investor

Add these five companies to your June shopping list as they are showing great earnings power and a desire to buy back stock to kick…

Trade of the Day: Buy IBB for a Double-Digit Run Into Year End

By Sam Collins, InvestorPlace Chief Technical Analyst

The recent correction provides an excellent entry point in iShares NASDAQ Biotechnology Index (ETF).

10 Smart Money Stocks to Buy for the Rest of the Year

By Harriet Lefton, Writer, TipRanks

These 10 smart money stocks to buy have significant support from top analysts. Here’s why each should help you flourish throughout the rest of the…

Trade of the Day: IBB is Your Best Bet in Biotech

By Sam Collins, InvestorPlace Chief Technical Analyst

iShares NASDAQ Biotechnology Index (ETF) looks ready to break out.

4 Biotech Stocks With Leaky Pipelines

By Regina Borsellino

A strong pipeline can make or break biotech stocks, ensuring strong profits for years to come. These four biotech companies don’t make the cut.

Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning Things Around

By Sam Collins, InvestorPlace Chief Technical Analyst

It has been a rough year for this biotechnology ETF, but several indicators suggest IBB is a good buy.

10 Stocks to Buy That Could Be Takeover Targets

By Vince Martin, InvestorPlace Contributor

Takeover targets can deliver big upside if an offer comes through. These 10 stocks to buy could be M&A targets and see big gains soon.

5 Biotech Stocks That Must Be Quarantined

By Anthony Mirhaydari, InvestorPlace Market Strategist

A number of biotech stocks in the sector look vulnerable to further profit-taking losses. Here are five to watch.

5 Cheap Biotech Stocks to Snag on the Bounce

By Anthony Mirhaydari, InvestorPlace Market Strategist

Biotech’s luck is changing as the trend looks to be upward and outward for the biotech stocks. These are the five to watch.

3 Biotech and Pharma Stocks with Key FDA Catalysts this October

By

Here is a look at three biotech and pharma stocks including Flexion (FLXN) that have an important regulatory event lined up this month.

4 Biotech Stocks Sliding Lower

By William Roth, InvestorPlace Market Strategist

Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.

Mutual Funds Spotlight – T. Rowe Price Health Science Fund

By Cynthia Wilson, Consumer Finance & Funds Writer

The T. Rowe Price Health Science Fund is a great example of sector mutual funds for investors looking to play one industry and capitalize on…

10 Biotech Stocks With Symptoms of Strong Growth

By James Brumley, InvestorPlace Feature Writer

Most sectors are overextended and ripe for weakness, but biotech stocks are the exception. Put these names on your list of stocks to buy this…

The 10 Best Stocks to Buy for the Rest of 2016

By James Brumley, InvestorPlace Feature Writer

These picks of the litter are among the best stocks to buy for a solid Q4, for fundamental, technical and even binary-event reasons.

Acquisition News Sends Gerber Scientific and EMS to New Highs

By Deborah OMalley, InvestorPlace Writer

Buyout and acquisition news sent Gerber Scientific NYSE:GRB and EMS Technologies NASDAQ:ELMG to new 52-week highs today, though tech stocks Hewlett-Packard NYSE:HPQ hit a new…

9 – 10 of 240 results